Published in Arch Biochem Biophys on May 27, 2009
A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer. FEBS J (2011) 1.70
Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics. J Med Chem (2010) 1.05
Mutation in spike protein cleavage site and pathogenesis of feline coronavirus. Emerg Infect Dis (2013) 0.98
A novel activation mechanism of avian influenza virus H9N2 by furin. J Virol (2013) 0.93
Platelet-derived growth factors and their receptors: structural and functional perspectives. Biochim Biophys Acta (2012) 0.91
Group X secreted phospholipase A2 proenzyme is matured by a furin-like proprotein convertase and releases arachidonic acid inside of human HEK293 cells. J Biol Chem (2011) 0.88
Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells. MAbs (2015) 0.81
A femtomol range FRET biosensor reports exceedingly low levels of cell surface furin: implications for the processing of anthrax protective antigen. PLoS One (2010) 0.78
Hysteretic behavior of proprotein convertase 1/3 (PC1/3). PLoS One (2011) 0.76
Effects of magnesium ions on recombinant human furin: selective activation of hydrolytic activity upon substrates derived from virus envelope glycoprotein. Biol Chem (2010) 0.76
A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site. PLoS One (2017) 0.75
Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits. Am J Hum Genet (2017) 0.75
On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun (1967) 18.32
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell (1988) 7.01
Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science (1985) 6.48
Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol (2002) 6.37
Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28
Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem (1992) 4.87
Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33
Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J (1997) 4.31
Structure of the immature dengue virus at low pH primes proteolytic maturation. Science (2008) 3.86
Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res (1999) 3.79
Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis. Trends Cell Biol (1999) 3.50
The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science (2008) 3.26
Prediction of proprotein convertase cleavage sites. Protein Eng Des Sel (2004) 3.05
Proteolytic processing in the secretory pathway. J Biol Chem (1999) 2.75
The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat Struct Biol (2003) 2.42
alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc Natl Acad Sci U S A (1998) 2.28
Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. J Virol (2002) 1.93
Precursor processing by kex2/furin proteases. Chem Rev (2002) 1.88
Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. Biochim Biophys Acta (2000) 1.70
Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. J Mol Biol (2005) 1.57
Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage. J Virol (1992) 1.50
The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). J Biol Chem (1994) 1.46
Proteolytic processing of Marburg virus glycoprotein. Virology (2000) 1.43
Quantitative characterization of furin specificity. Energetics of substrate discrimination using an internally consistent set of hexapeptidyl methylcoumarinamides. J Biol Chem (1999) 1.41
Substrate cleavage analysis of furin and related proprotein convertases. A comparative study. J Biol Chem (2008) 1.40
A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. J Virol (1994) 1.38
Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases. Biochem J (1996) 1.27
Inhibition of furin by polyarginine-containing peptides: nanomolar inhibition by nona-D-arginine. J Biol Chem (2004) 1.26
Understanding influenza virus pathogenicity. Trends Microbiol (1999) 1.26
Measuring elastase, proteinase 3 and cathepsin G activities at the surface of human neutrophils with fluorescence resonance energy transfer substrates. Nat Protoc (2008) 1.18
The kindest cuts of all: crystal structures of Kex2 and furin reveal secrets of precursor processing. Trends Biochem Sci (2004) 1.16
A survey of furin substrate specificity using substrate phage display. Protein Sci (1994) 1.13
The hemagglutinin cleavability of a virulent avian influenza virus by subtilisin-like endoproteases is influenced by the amino acid immediately downstream of the cleavage site. Virology (1995) 1.07
Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1. FEBS Lett (1995) 1.07
Structural basis for differences in substrate selectivity in Kex2 and furin protein convertases. Biochemistry (2004) 1.01
Endoprotease activities other than furin and PACE4 with a role in processing of HIV-I gp160 glycoproteins in CHO-K1 cells. J Biol Chem (1997) 1.00
In vitro cleavage of internally quenched fluorogenic human proparathyroid hormone and proparathyroid-related peptide substrates by furin. Generation of a potent inhibitor. J Biol Chem (1998) 0.98
Furin cleavage of the HIV-1 Tat protein. FEBS Lett (2004) 0.92
Specific modulation of Kex2/furin family proteases by potassium. J Biol Chem (2002) 0.89
Fluorescent properties of amino acids labeled with ortho-aminobenzoic acid. Biospectroscopy (1998) 0.87
Purification and characterization of a Ca2+-independent endoprotease activity from peripheral blood lymphocytes: involvement in HIV-1 gp160 maturation. Biochemistry (2001) 0.87
Ionization of methyl derivatives of imidazole, histidine, thyreotropin releasing factor, and related compounds. J Am Chem Soc (1976) 0.85
Plasticity of extended subsites facilitates divergent substrate recognition by Kex2 and furin. J Biol Chem (2004) 0.85
Internally quenched fluorogenic substrate for furin. Anal Biochem (1995) 0.84
Structural investigation and kinetic characterization of potential cleavage sites of HIV GP160 by human furin and PC1. Biochem Biophys Res Commun (1995) 0.79
The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat Struct Biol (2003) 2.42
Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci U S A (2002) 2.19
A multifunctional serine protease primes the malaria parasite for red blood cell invasion. EMBO J (2009) 1.67
Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J (2002) 1.58
Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. J Mol Biol (2005) 1.57
Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase. Biochem J (2006) 1.49
Defective transport of the obesity mutant PC1/3 N222D contributes to loss of function. Endocrinology (2014) 1.40
Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development. J Biol Chem (2003) 1.35
The route of antimicrobial resistance from the hospital effluent to the environment: focus on the occurrence of KPC-producing Aeromonas spp. and Enterobacteriaceae in sewage. Diagn Microbiol Infect Dis (2013) 1.30
Inhibition of furin by polyarginine-containing peptides: nanomolar inhibition by nona-D-arginine. J Biol Chem (2004) 1.26
Characterization of unusual families of ATG8-like proteins and ATG12 in the protozoan parasite Leishmania major. Autophagy (2009) 1.26
Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling. J Biol Chem (2008) 1.20
Measuring elastase, proteinase 3 and cathepsin G activities at the surface of human neutrophils with fluorescence resonance energy transfer substrates. Nat Protoc (2008) 1.18
Membrane fusion induced by vesicular stomatitis virus depends on histidine protonation. J Biol Chem (2003) 1.17
Metacaspase 2 of Trypanosoma brucei is a calcium-dependent cysteine peptidase active without processing. FEBS Lett (2007) 1.16
ATP effects on insulin-degrading enzyme are mediated primarily through its triphosphate moiety. J Biol Chem (2004) 1.15
Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein. Biochem J (2003) 1.12
Mapping of the catalytic groove preferences of factor Xa reveals an inadequate selectivity for its macromolecule substrates. J Biol Chem (2002) 1.12
Increase in kinins on post-exercise hypotension in normotensive and hypertensive volunteers. Biol Chem (2007) 1.10
Protection against anthrax toxemia by hexa-D-arginine in vitro and in vivo. Infect Immun (2004) 1.10
The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo. Infect Immun (2002) 1.09
Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia. J Bone Miner Res (2013) 1.06
Processing of proaugurin is required to suppress proliferation of tumor cell lines. Mol Endocrinol (2011) 1.06
Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics. J Med Chem (2010) 1.05
Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species. J Biol Chem (2005) 1.05
A glimpse on biological activities of tellurium compounds. An Acad Bras Cienc (2009) 1.03
Detection of SPM-1-producing Pseudomonas aeruginosa and class D β-lactamase-producing Acinetobacter baumannii isolates by use of liquid chromatography-mass spectrometry and matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2012) 1.03
The cystatin-related epididymal spermatogenic protein inhibits the serine protease prohormone convertase 2. Endocrinology (2003) 1.02
SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathway. Am J Pathol (2007) 1.02
Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases. J Biol Chem (2009) 1.01
7B2 prevents unfolding and aggregation of prohormone convertase 2. Endocrinology (2008) 1.01
Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects. J Biol Chem (2005) 1.01
Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities. PLoS One (2008) 1.00
Biosynthesis of proopiomelanocortin-derived peptides in prohormone convertase 2 and 7B2 null mice. Endocrinology (2003) 1.00
Functional characterization of ProSAAS: similarities and differences with 7B2. J Biol Chem (2001) 0.99
Metagenomic analysis of a tropical composting operation at the são paulo zoo park reveals diversity of biomass degradation functions and organisms. PLoS One (2013) 0.99
Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1. Proc Natl Acad Sci U S A (2005) 0.99
Trypanosoma brucei metacaspase 4 is a pseudopeptidase and a virulence factor. J Biol Chem (2011) 0.99
Design and use of highly specific substrates of neutrophil elastase and proteinase 3. Am J Respir Cell Mol Biol (2003) 0.99
Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort. Gastroenterology (2013) 0.99
Cathepsin X binds to cell surface heparan sulfate proteoglycans. Arch Biochem Biophys (2005) 0.99
A continuous fluorescence resonance energy transfer angiotensin I-converting enzyme assay. Nat Protoc (2006) 0.99
Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype. J Bone Miner Res (2013) 0.99
T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain. J Autoimmun (2005) 0.99
Cross-inhibition between furin and lethal factor inhibitors. Biochem Biophys Res Commun (2004) 0.98
Cysteine-protease activity elicited by Ca2+ stimulus in Plasmodium. Mol Biochem Parasitol (2005) 0.98
Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins. J Cell Sci (2007) 0.98
Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases. J Biol Chem (2012) 0.98
Mutation of active site residues of insulin-degrading enzyme alters allosteric interactions. J Biol Chem (2005) 0.97
Purification, characterization and substrate specificity of a trypsin from the Amazonian fish tambaqui (Colossoma macropomum). Biochem Biophys Res Commun (2010) 0.96
Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain. J Biol Chem (2001) 0.96
Amylolytic microorganism from são paulo zoo composting: isolation, identification, and amylase production. Enzyme Res (2011) 0.94
Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans. J Biol Chem (2007) 0.94
Influence of charge distribution at the active site surface on the substrate specificity of human neutrophil protease 3 and elastase. A kinetic and molecular modeling analysis. J Biol Chem (2006) 0.94
Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxydipeptidases: assays with human cathepsin B. Anal Biochem (2004) 0.93
Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury. Br J Pharmacol (2003) 0.92
Role of GP82 in the selective binding to gastric mucin during oral infection with Trypanosoma cruzi. PLoS Negl Trop Dis (2010) 0.92
Amidolytic activity of prostatic acid phosphatase on human semenogelins and semenogelin-derived synthetic substrates. Eur J Biochem (2002) 0.92
Deorphanization of novel peptides and their receptors. AAPS J (2010) 0.92
Natural polyprenylated benzophenones inhibiting cysteine and serine proteases. Eur J Med Chem (2008) 0.91
Probing cathepsin K activity with a selective substrate spanning its active site. Biochem J (2003) 0.91
The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins. J Biol Chem (2012) 0.91
Probing the interaction between vesicular stomatitis virus and phosphatidylserine. Eur Biophys J (2005) 0.91
Molecular characterization of an acidic phospholipase A(2) from Bothrops pirajai snake venom: synthetic C-terminal peptide identifies its antiplatelet region. Arch Toxicol (2011) 0.90
Short polybasic peptide sequences are potent inhibitors of PC5/6 and PC7: Use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences. Mol Pharmacol (2006) 0.90
Strain-dependent influences on the hypothalamo-pituitary-adrenal axis profoundly affect the 7B2 and PC2 null phenotypes. Endocrinology (2005) 0.90
Identification of the allosteric regulatory site of insulysin. PLoS One (2011) 0.90
Functional consequences of a novel variant of PCSK1. PLoS One (2013) 0.90
Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth. Mol Cancer (2007) 0.89
Generation and characterization of non-competitive furin-inhibiting nanobodies. Biochem J (2012) 0.89
β-Actin-binding complementarity-determining region 2 of variable heavy chain from monoclonal antibody C7 induces apoptosis in several human tumor cells and is protective against metastatic melanoma. J Biol Chem (2012) 0.89
In vitro and in vivo degradation of Abeta peptide by peptidases coupled to erythrocytes. Peptides (2007) 0.88
On the mechanisms of phenothiazine-induced mitochondrial permeability transition: Thiol oxidation, strict Ca2+ dependence, and cyt c release. Biochem Pharmacol (2010) 0.88
Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates. J Biol Chem (2002) 0.88
Identification of bradykinins in solitary wasp venoms. Toxicon (2002) 0.88
Production of bioactive peptides in an in vitro system. Anal Biochem (2007) 0.88
Hydrolytic properties and substrate specificity of the foot-and-mouth disease leader protease. Biochemistry (2009) 0.88
Immune evasion by pathogenic Leptospira strains: the secretion of proteases that directly cleave complement proteins. J Infect Dis (2013) 0.88
Inhibition of neutrophil elastase by alpha1-protease inhibitor at the surface of human polymorphonuclear neutrophils. J Immunol (2005) 0.88
Comparative substrate specificity analysis of recombinant human cathepsin V and cathepsin L. Arch Biochem Biophys (2004) 0.87
Prohormone convertase 1 (PC1) processing and sorting: effect of PC1 propeptide and proSAAS. J Endocrinol (2004) 0.87